Nutritional status and feeding-tube placement in patients with locally advanced hypopharyngeal cancer included in an induction chemotherapy-based larynx preservation program

被引:12
|
作者
Bozec, Alexandre [1 ]
Benezery, Karen [2 ]
Chamorey, Emmanuel [3 ]
Ettaiche, Marc [3 ]
Vandersteen, Clair [1 ]
Dassonville, Olivier [1 ]
Poissonnet, Gilles [1 ]
Riss, Jean-Christophe [1 ]
Hannoun-Levi, Jean-Michel [2 ]
Chand, Marie-Eve [2 ]
Leysalle, Axel [2 ]
Saada, Esma [4 ]
Sudaka, Anne [5 ]
Haudebourg, Juliette [5 ]
Hebert, Christophe [6 ]
Falewee, Marie-Noelle [6 ]
Demard, Francois [1 ]
Santini, Jose [1 ]
Peyrade, Frederic [4 ]
机构
[1] Inst Univ Face & Cou, 31 Ave Valombrose, F-06103 Nice, France
[2] Ctr Antoine Lacassagne, Dept Radiotherapy, 33 Ave Valombrose, F-06103 Nice, France
[3] Ctr Antoine Lacassagne, Dept Stat, 33 Ave Valombrose, F-06103 Nice, France
[4] Ctr Antoine Lacassagne, Dept Med Oncol, 33 Ave Valombrose, F-06103 Nice, France
[5] Ctr Antoine Lacassagne, Dept Pathol, 33 Ave Valombrose, F-06103 Nice, France
[6] Ctr Antoine Lacassagne, Dept Nutr, 33 Ave Valombrose, F-06103 Nice, France
关键词
Hypopharynx; Cancer; Treatment; Nutrition; Enteral feeding tube; Functional outcome; QUALITY-OF-LIFE; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; NECK-CANCER; HEAD; CHEMORADIOTHERAPY; MALNUTRITION; IMPACT; TRIAL;
D O I
10.1007/s00405-015-3785-4
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
The objective of the study is to evaluate the nutritional status and determine its impact on clinical outcomes in patients with locally advanced hypopharyngeal cancer included in an induction chemotherapy (ICT)-based larynx preservation program without prophylactic feeding-tube placement. All patients with locally advanced (T3/4, N0-3, M0) hypopharyngeal squamous cell carcinoma, technically suitable for total pharyngolaryngectomy, treated by docetaxel, cisplatin and 5-fluorouracil (TPF)-ICT for larynx preservation at our institution between 2004 and 2013, were included in this retrospective study. Patients' nutritional status was closely monitored. Enteral nutrition was used if and when a patient was unable to sustain per-oral nutrition and hydration. The impact of nutritional status on clinical outcomes was investigated in univariate and multivariate analysis. A total of 53 patients (42 men and 11 women, mean age = 58.6 +/- 8.2 years) were included in this study. Six (11.3 %) patients had lost more than 10 % of their usual body weight before therapy. Compared with patients' usual weight, the mean maximum patient weight loss during therapeutic management was 8.7 +/- 4.5 kg. Enteral nutrition was required in 17 patients (32 %). We found no influence of the tested nutritional status-related factors on response to ICT, toxicity of ICT, overall, cause-specific and recurrence-free survival, and on post-therapeutic swallowing outcome. Maximum weight loss was significantly associated with a higher risk of enteral tube feeding during therapy (p = 0.03) and of complications (grade aeyen3, p = 0.006) during RT. Without prophylactic feeding-tube placement, approximately one-third of the patients required enteral nutrition. There was no significant impact of nutritional status on oncologic or functional outcomes.
引用
收藏
页码:2681 / 2687
页数:7
相关论文
共 27 条
  • [21] Evaluation of a prognostic scoring system based on the systemic inflammatory and nutritional status of patients with locally advanced non-small-cell lung cancer treated with chemoradiotherapy
    Mitsuyoshi, Takamasa
    Matsuo, Yukinori
    Itou, Hitoshi
    Shintani, Takashi
    Iizuka, Yusuke
    Kim, Young Hak
    Mizowaki, Takashi
    JOURNAL OF RADIATION RESEARCH, 2018, 59 (01) : 50 - 57
  • [22] Phase II Study of Preoperative Capecitabine and Oxaliplatin-based Intensified Chemoradiotherapy With or Without Induction Chemotherapy in Patients With Locally Advanced Rectal Cancer and Synchronous Liver-limited Resectable Metastases
    Cho, Hyungwoo
    Kim, Jeong Eun
    Kim, Kyu-Pyo
    Yu, Chang Sik
    Kim, Jin Cheon
    Kim, Jong Hoon
    Lee, Myung Ah
    Jang, Hong Seok
    Oh, Seong Taek
    Kim, Sun Young
    Oh, Jae Hwan
    Kim, Dae Yong
    Hong, Yong Sang
    Kim, Tae Won
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (06): : 623 - 629
  • [23] Long-term oncological and functional outcomes of induction chemotherapy followed by (chemo)radiotherapy vs definitive chemoradiotherapy vs surgery-based therapy in locally advanced stage III/IV hypopharyngeal cancer: Multicenter review of 266 cases
    Chung, Eun-Jae
    Jeong, Woo-Jin
    Jung, Young Ho
    Kwon, Seong Keun
    Kwon, Tack-Kyun
    Ahn, Soon-Hyun
    Sung, Myung-Whun
    Keam, Bhumsuk
    Heo, Dae-Seog
    Kim, Jin Ho
    Wu, Hong-Gyun
    Lee, Keun-Wook
    Eom, Keun-Yong
    Rho, Young-Soo
    ORAL ONCOLOGY, 2019, 89 : 84 - 94
  • [24] Nab-Paclitaxel, Capecitabine, and Radiation Therapy After Induction Chemotherapy in Treating Patients With Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase 1 Trial and Imaging-based Biomarker Validation
    Koay, Eugene J.
    Zaid, Mohamed
    Aliru, Maureen
    Bagereka, Polycarpe
    Van Wieren, Arie
    Rodriguez, Maria Jovie
    Jacobson, Galia
    Wolff, Robert A.
    Overman, Michael
    Varadhachary, Gauri
    Pant, Shubham
    Wang, Huamin
    Tzeng, Ching-Wei
    Ikoma, Naruhiko
    Kim, Michael
    Lee, Jeffrey E.
    Katz, Matthew HG.
    Tamm, Eric
    Bhosale, Priya
    Taniguchi, Cullen M.
    Holliday, Emma B.
    Smith, Grace L.
    Ludmir, Ethan B.
    Minsky, Bruce D.
    Crane, Christopher H.
    Koong, Albert C.
    Das, Prajnan
    Wang, Xuemei
    Javle, Milind
    Krishnan, Sunil
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : 444 - 453
  • [25] Characteristics of toxicity occurrence patterns in concurrent chemoradiotherapy after induction chemotherapy for patients with locally advanced non-small-cell lung cancer: a pooled analysis based on individual patient data of CALGB/Alliance trials
    Yang, Lexie Zidanyue
    He, Qihua
    Zhang, Jianrong
    Ganti, Apar Kishor
    Stinchcombe, Thomas E.
    Pang, Herbert
    Wang, Xiaofei
    TRANSLATIONAL CANCER RESEARCH, 2022, : 3506 - 3521
  • [26] Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management
    Smith, J. Joshua
    Chow, Oliver S.
    Gollub, Marc J.
    Nash, Garrett M.
    Temple, Larissa K.
    Weiser, Martin R.
    Guillem, Jose G.
    Paty, Philip B.
    Avila, Karin
    Garcia-Aguilar, Julio
    BMC CANCER, 2015, 15
  • [27] Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study
    Driessen, C. M. L.
    de Boer, J. P.
    Gelderblom, H.
    Rasch, C. R. N.
    de Jong, M. A.
    Verbist, B. M.
    Melchers, W. J. G.
    Tesselaar, M. E. T.
    van der Graaf, W. T. A.
    Kaanders, J. H. A. M.
    van Herpen, C. M. L.
    EUROPEAN JOURNAL OF CANCER, 2016, 52 : 77 - 84